Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression
about
sameAs
Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolismTrimethylaminuria: causes and diagnosis of a socially distressing conditionRole of reactive metabolites in the circulation in extrahepatic toxicityDevelopmental pharmacokinetics in pediatric populationsPrenatal and postnatal expression of glutathione transferase ζ 1 in human liver and the roles of haplotype and subject age in determining activity with dichloroacetateGenetic polymorphisms of human flavin-containing monooxygenase 3: implications for drug metabolism and clinical perspectivesPurification and characterization of flavin-containing monooxygenase isoform 3 from rat kidney microsomesChildhood brain tumors, residential insecticide exposure, and pesticide metabolism genesFlavin-Containing Monooxygenase 3 Reduces Endoplasmic Reticulum Stress in Lipid-Treated HepatocytesFlavin-containing monooxygenase S-oxygenation of a series of thioureas and thiones.Mammalian flavin-containing monooxygenase (FMO) as a source of hydrogen peroxideSex-specific gene expression in the BXD mouse liverFish odor syndrome (trimethylaminuria) supporting the possible FMO3 down expression in childhood: a case report.Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism.Tolerance to acetaminophen hepatotoxicity in the mouse model of autoprotection is associated with induction of flavin-containing monooxygenase-3 (FMO3) in hepatocytes.Human hepatic UGT2B15 developmental expression.Developmental variations in metabolic capacity of flavin-containing mono-oxygenase 3 in childhood.Clinical utility gene card for: trimethylaminuria.Clinical utility gene card for: Trimethylaminuria - update 2014Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug development.The role of flavin-containing monooxygenase (FMO) in the metabolism of tamoxifen and other tertiary amines.Developmental and tissue-specific expression of human flavin-containing monooxygenases 1 and 3.Metabolism of the anti-tuberculosis drug ethionamide by mouse and human FMO1, FMO2 and FMO3 and mouse and human lung microsomesQuantification of Flavin-containing Monooxygenases 1, 3, and 5 in Human Liver Microsomes by UPLC-MRM-Based Targeted Quantitative Proteomics and Its Application to the Study of Ontogeny.Expression Patterns of Organic Anion Transporting Polypeptides 1B1 and 1B3 Protein in Human Pediatric LiverReaction phenotyping: current industry efforts to identify enzymes responsible for metabolizing drug candidates.Genome-wide association identifies genetic variants associated with lentiform nucleus volume in N = 1345 young and elderly subjectsRole of farnesoid X receptor in establishment of ontogeny of phase-I drug metabolizing enzyme genes in mouse liver.RNA-sequencing quantification of hepatic ontogeny of phase-I enzymes in mice.Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease.Relationships between flavin-containing mono-oxygenase 3 (FMO3) genotype and trimethylaminuria phenotype in a Japanese population.The potential of knockout mouse lines in defining the role of flavin-containing monooxygenases in drug metabolism.Ontogeny of mammalian metabolizing enzymes in humans and animals used in toxicological studies.Inter-individual variation in flavin-containing monooxygenase 3 in livers from Japanese: correlation with hepatic transcription factors.Genetic and Non-genetic Factors Associated with Protein Abundance of Flavin-containing Monooxygenase 3 in Human Liver.Trimethylamine-The Extracorporeal Envoy.Specific features of pharmacokinetics in children.Non-cytochrome P450-mediated bioactivation and its toxicological relevance.Drug metabolism by flavin-containing monooxygenases of human and mouse.Alternative promoters and repetitive DNA elements define the species-dependent tissue-specific expression of the FMO1 genes of human and mouse.
P2860
Q22251223-20089D9F-50CE-4AA8-8F4C-E677AA824C84Q24604974-9258DEDB-A9DB-4281-85EA-C356CB712832Q26849288-9E75B012-B1A2-49F8-B8C4-F16A123C1B6EQ27002933-31CEC83D-A126-4BD0-87BC-19FE908F814EQ28251446-8B7E9B56-1D40-424C-AECB-9B582B809198Q28305656-D59ACFBB-A770-4306-ADF3-5A9832D212AAQ28570869-4DFCD4B2-FDDA-49A3-891A-FD0A8B16066CQ33522508-527226C4-DF4D-4F25-A4E4-DCDCAC75C547Q33631394-B1AE55FC-1A93-426A-9EF2-57935BAE34A9Q33946752-5B5E6AFE-1C7A-4C63-A3D5-AA823FDD806FQ33976014-ECF8E6A8-B205-40CE-8CEA-B6681210C8A0Q34090751-F906BD8B-A877-4591-8648-0F1A7C5FFF5EQ34310097-9DB6953F-E53A-4DBD-858B-D0911F7CDC92Q34673357-994959D1-506F-47F3-A932-94889A22B0AFQ34737067-84181675-CA0F-44A7-9859-2BAC4A3BE998Q34737080-1551A801-41CA-46D8-9251-D006016D162FQ34830115-1A939522-6D50-449D-A337-B084EF82A16EQ35768377-4A352145-DF93-4976-AF9D-815E52CD6E96Q35959740-5EA2DEB5-057C-4557-B045-DB5511AB3C53Q36316996-F7F3F000-DAFB-490A-8CD3-D26323BD0B8BQ36473486-42FD8B08-8D9C-479E-A0EF-00972D1C1344Q36545025-BCB65FE4-0E81-4538-AABC-AB039D1FB3F2Q37060764-9CE1E285-37F3-4059-8293-B6E2965DAA19Q37062604-EAB5C832-135F-45F1-8C0E-4B4EC2B16C41Q37062634-61217A57-7894-446F-84D3-7CCD52C7D567Q37150887-26A19359-B0CF-48F5-AE1E-4699DBD99AB4Q37187804-DF1BECC2-D844-4DC3-8A41-8B5F1FEF6CE6Q37302200-1F536884-CAAF-465E-A7AD-4E346B1688BFQ37325574-EB9393A2-7851-46A1-8521-E293AD898CBBQ37357727-F8F28E6C-BB25-4E5C-AA5C-19CD0435AD6BQ37731862-F08F5FAD-3BC7-40E7-AA41-5E2B7A992C86Q37772507-8F628ED3-178A-43B0-AEC5-7D3A71AF2769Q38003479-CD633A49-43F4-4B62-95B9-E65AB760FF90Q38510442-08D941BB-E685-4E6A-BF64-DB9989555497Q38619177-4BE9C04E-DDB8-448B-BC9C-531020D32B5EQ38711287-4E267E43-A9D6-4960-A74D-8F3D3C6DB30DQ38717340-4B977BA0-D70B-44D8-9588-1259CC3EE0A5Q38929936-18FBEE0A-BBFD-4717-A361-EE425CAA5899Q38966423-7EB188A6-455F-4B5A-95CF-EDE9017997BAQ39253466-93B3040B-FA65-4DBC-A0E3-634C1730129B
P2860
Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Human hepatic flavin-containin ...... FMO3) developmental expression
@ast
Human hepatic flavin-containin ...... FMO3) developmental expression
@en
Human hepatic flavin-containin ...... FMO3) developmental expression
@nl
type
label
Human hepatic flavin-containin ...... FMO3) developmental expression
@ast
Human hepatic flavin-containin ...... FMO3) developmental expression
@en
Human hepatic flavin-containin ...... FMO3) developmental expression
@nl
prefLabel
Human hepatic flavin-containin ...... FMO3) developmental expression
@ast
Human hepatic flavin-containin ...... FMO3) developmental expression
@en
Human hepatic flavin-containin ...... FMO3) developmental expression
@nl
P2093
P2860
P3181
P1433
P1476
Human hepatic flavin-containin ...... FMO3) developmental expression
@en
P2093
Allan E Rettie
Catherine K Yeung
Pippa Simpson
Sevasti B Koukouritaki
P2860
P304
P3181
P356
10.1203/00006450-200202000-00018
P407
P577
2002-02-01T00:00:00Z
P5875
P6179
1029528056